Features of the intestinal microbiota composition in multiple sclerosis patients receiving oral disease-modifying therapyЕ. А. Тарасова, И. Н. Абдурасулова, A. G. Ilves et al.|Medical academic journal|2021Cited by 4
Multiple sclerosis progression and galanin receptor GALR2: is there evidence for a link?Victoria Lioudyno, И. Н. Абдурасулова, A. G. Ilves et al.|Medical academic journal|2021Cited by 0